CID 16133604

5'-d(ccccca)td(gga)-3', phosphorothioate oligodeoxynucleotide

Structural Information

Molecular Formula
C95H122N37O48P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8CO)N9C=CC(=NC9=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)OP(=O)(OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)O)S
InChI
InChI=1S/C95H122N37O48P9S9/c1-39-22-128(95(143)122-85(39)135)71-18-46(177-187(150,196)160-32-59-49(21-74(171-59)132-38-112-78-84(132)119-89(104)121-87(78)137)180-189(152,198)161-31-58-48(20-73(170-58)131-37-111-77-83(131)118-88(103)120-86(77)136)178-181(144,190)153-24-51-40(134)12-65(163-51)129-35-109-75-79(101)105-33-107-81(75)129)56(168-71)29-158-188(151,197)179-47-19-72(130-36-110-76-80(102)106-34-108-82(76)130)169-57(47)30-159-186(149,195)176-45-17-70(127-11-6-64(100)117-94(127)142)167-55(45)28-157-185(148,194)175-44-16-69(126-10-5-63(99)116-93(126)141)166-54(44)27-156-184(147,193)174-43-15-68(125-9-4-62(98)115-92(125)140)165-53(43)26-155-183(146,192)173-42-14-67(124-8-3-61(97)114-91(124)139)164-52(42)25-154-182(145,191)172-41-13-66(162-50(41)23-133)123-7-2-60(96)113-90(123)138/h2-11,22,33-38,40-59,65-74,133-134H,12-21,23-32H2,1H3,(H,144,190)(H,145,191)(H,146,192)(H,147,193)(H,148,194)(H,149,195)(H,150,196)(H,151,197)(H,152,198)(H2,96,113,138)(H2,97,114,139)(H2,98,115,140)(H2,99,116,141)(H2,100,117,142)(H2,101,105,107)(H2,102,106,108)(H,122,135,143)(H3,103,118,120,136)(H3,104,119,121,137)
InChIKey
LOALDODGMRWCRS-UHFFFAOYSA-N
Compound name
1-[4-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-sulfanylphosphoryl]oxy-5-[[[2-[[[5-(4-amino-2-oxopyrimidin-1-yl)-2-[[[5-(4-amino-2-oxopyrimidin-1-yl)-2-[[[5-(4-amino-2-oxopyrimidin-1-yl)-2-[[[5-(4-amino-2-oxopyrimidin-1-yl)-2-[[[5-(4-amino-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

3115.337 Da
Monoisotopic Mass

-6.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3116.3443 293.9
[M+Na]+ 3138.3262 298.3
[M-H]- 3114.3297 294.8
[M+NH4]+ 3133.3708 295.6
[M+K]+ 3154.3002 296.1
[M+H-H2O]+ 3098.3343 294.4
[M+HCOO]- 3160.3352 295.8
[M+CH3COO]- 3174.3509 296.2
[M+Na-2H]- 3136.3117 299.8
[M]+ 3115.3365 298.2
[M]- 3115.3375 298.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.